CD&R, Merck GHI and McKesson Ventures to invest in M2GEN

Clayton, Dubilier & Rice, the Merck Global Health Innovation Fund and McKesson Ventures have invested in M2GEN, a cancer data and informatics platform.

17 March 2021•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles